APO Research

APO RESEARCH · REPORT

HPV Vaccine for Men(Male HPV Vaccine)

Selected research

Market Structure

Global HPV Vaccine for Men(Male HPV Vaccine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global HPV Vaccine for Men(Male HPV Vaccine) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HPV Vaccine for Men(Male HPV Vaccine) include Bovaxbio, Kangle Guardian, Merck and Wantai Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global HPV Vaccine for Men(Male HPV Vaccine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HPV Vaccine for Men(Male HPV Vaccine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HPV Vaccine for Men(Male HPV Vaccine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HPV Vaccine for Men(Male HPV Vaccine) market size, projected growth trends, production technologies, key applications, and end-use industries.

HPV Vaccine for Men(Male HPV Vaccine) Segment by Company

Bovaxbio

Kangle Guardian

Merck

Wantai Biotech

HPV Vaccine for Men(Male HPV Vaccine) Segment by Type

Domestic

Imported

HPV Vaccine for Men(Male HPV Vaccine) Segment by Application

Penile Cancer and Precancerous Lesions

Genital Warts

Perineal Cancer and Precancerous Lesions

Perianal Cancer and Precancerous Lesions

Others

HPV Vaccine for Men(Male HPV Vaccine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Vaccine for Men(Male HPV Vaccine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HPV Vaccine for Men(Male HPV Vaccine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Vaccine for Men(Male HPV Vaccine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the HPV Vaccine for Men(Male HPV Vaccine) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HPV Vaccine for Men(Male HPV Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of HPV Vaccine for Men(Male HPV Vaccine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of HPV Vaccine for Men(Male HPV Vaccine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. HPV Vaccine for Men(Male HPV Vaccine) Industry Trends Table 2. HPV Vaccine for Men(Male HPV Vaccine) Industry Drivers Table 3. HPV Vaccine for Men(Male HPV Vaccine) Industry Opportunities and Challenges Table 4. HPV Vaccine for Men(Male HPV Vaccine) Industry Restraints Table 5. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Manufacturers Table 9. Global HPV Vaccine for Men(Male HPV Vaccine) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global HPV Vaccine for Men(Male HPV Vaccine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global HPV Vaccine for Men(Male HPV Vaccine) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global HPV Vaccine for Men(Male HPV Vaccine) Manufacturers, Product Type & Application Table 13. Global HPV Vaccine for Men(Male HPV Vaccine) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global HPV Vaccine for Men(Male HPV Vaccine) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Domestic Table 17. Major Manufacturers of Imported Table 18. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021-2026) & (K Units) Table 20. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2027-2032) & (K Units) Table 21. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2021-2026) Table 22. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2027-2032) Table 23. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2021-2026) & (K Units) Table 25. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2027-2032) & (K Units) Table 26. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2021-2026) Table 27. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Penile Cancer and Precancerous Lesions Table 29. Major Manufacturers of Genital Warts Table 30. Major Manufacturers of Perineal Cancer and Precancerous Lesions Table 31. Major Manufacturers of Perianal Cancer and Precancerous Lesions Table 32. Major Manufacturers of Others Table 33. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021-2026) & (K Units) Table 35. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2027-2032) & (K Units) Table 36. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2021-2026) Table 37. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2027-2032) Table 38. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2021-2026) & (K Units) Table 40. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2027-2032) & (K Units) Table 41. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2021-2026) Table 42. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2027-2032) Table 43. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021-2026) & (K Units) Table 45. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Region (2021-2026) Table 46. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Forecasted Market Share by Region (2027-2032) Table 48. North America HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026) & (K Units) Table 50. North America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2027-2032) & (K Units) Table 51. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026) & (K Units) Table 53. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2027-2032) & (K Units) Table 60. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2021-2026) & (US$ Million) Table 62. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2027-2032) & (US$ Million) Table 63. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Region (2021-2026) Table 64. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Region (2027-2032) Table 65. Bovaxbio Company Information Table 66. Bovaxbio Business Overview Table 67. Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio Table 69. Bovaxbio Recent Development Table 70. Kangle Guardian Company Information Table 71. Kangle Guardian Business Overview Table 72. Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio Table 74. Kangle Guardian Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merck HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio Table 79. Merck Recent Development Table 80. Wantai Biotech Company Information Table 81. Wantai Biotech Business Overview Table 82. Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio Table 84. Wantai Biotech Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. HPV Vaccine for Men(Male HPV Vaccine) Distributors List Table 88. HPV Vaccine for Men(Male HPV Vaccine) Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. HPV Vaccine for Men(Male HPV Vaccine) Product Image Figure 2. Global HPV Vaccine for Men(Male HPV Vaccine) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HPV Vaccine for Men(Male HPV Vaccine) Market Size (2021-2032) & (US$ Million) Figure 4. Global HPV Vaccine for Men(Male HPV Vaccine) Sales (2021-2032) & (K Units) Figure 5. Global HPV Vaccine for Men(Male HPV Vaccine) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 HPV Vaccine for Men(Male HPV Vaccine) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Domestic Image Figure 9. Imported Image Figure 10. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2021-2032) Figure 13. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2021-2032) Figure 16. Penile Cancer and Precancerous Lesions Image Figure 17. Genital Warts Image Figure 18. Perineal Cancer and Precancerous Lesions Image Figure 19. Perianal Cancer and Precancerous Lesions Image Figure 20. Others Image Figure 21. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2021-2032) Figure 24. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2021-2032) Figure 27. North America HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021-2032) Figure 29. U.S. HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021-2032) Figure 34. Germany HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021-2032) Figure 41. China HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021-2032) Figure 49. Brazil HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile HPV Vaccine for Men(Male HPV Vaccine) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032) & (US$ Million) Figure 60. North America HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032) & (US$ Million) Figure 62. Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. HPV Vaccine for Men(Male HPV Vaccine) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. HPV Vaccine for Men(Male HPV Vaccine) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Domestic
  • Imported
Applications
  • Penile Cancer and Precancerous Lesions
  • Genital Warts
  • Perineal Cancer and Precancerous Lesions
  • Perianal Cancer and Precancerous Lesions
  • Others
Companies covered
  • Bovaxbio
  • Kangle Guardian
  • Merck
  • Wantai Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global HPV Vaccine for Men(Male HPV Vaccine) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global HPV Vaccine for Men(Male HPV Vaccine) Market Dynamics
  1. 2.1 HPV Vaccine for Men(Male HPV Vaccine) Industry Trends
  2. 2.2 HPV Vaccine for Men(Male HPV Vaccine) Industry Drivers
  3. 2.3 HPV Vaccine for Men(Male HPV Vaccine) Industry Opportunities and Challenges
  4. 2.4 HPV Vaccine for Men(Male HPV Vaccine) Industry Restraints
3 HPV Vaccine for Men(Male HPV Vaccine) Market by Manufacturers
  1. 3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Manufacturers (2021-2026)
  3. 3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global HPV Vaccine for Men(Male HPV Vaccine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HPV Vaccine for Men(Male HPV Vaccine) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global HPV Vaccine for Men(Male HPV Vaccine) Manufacturers, Product Type & Application
  7. 3.7 Global HPV Vaccine for Men(Male HPV Vaccine) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HPV Vaccine for Men(Male HPV Vaccine) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HPV Vaccine for Men(Male HPV Vaccine) Tier 1, Tier 2, and Tier 3
4 HPV Vaccine for Men(Male HPV Vaccine) Market by Type
  1. 4.1 HPV Vaccine for Men(Male HPV Vaccine) Type Introduction
  2. 4.1.1 Domestic
  3. 4.1.2 Imported
  4. 4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type
  5. 4.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021-2032)
  7. 4.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2021-2032)
  8. 4.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type
  9. 4.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2021-2032)
  11. 4.3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2021-2032)
5 HPV Vaccine for Men(Male HPV Vaccine) Market by Application
  1. 5.1 HPV Vaccine for Men(Male HPV Vaccine) Application Introduction
  2. 5.1.1 Penile Cancer and Precancerous Lesions
  3. 5.1.2 Genital Warts
  4. 5.1.3 Perineal Cancer and Precancerous Lesions
  5. 5.1.4 Perianal Cancer and Precancerous Lesions
  6. 5.1.5 Others
  7. 5.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application
  8. 5.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021-2032)
  10. 5.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2021-2032)
  11. 5.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application
  12. 5.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2021-2032)
  14. 5.3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2021-2032)
6 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region
  1. 6.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021-2032)
  3. 6.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021-2026)
  4. 6.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region
  1. 7.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region
  2. 7.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2021-2026)
  4. 7.1.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2027-2032)
  5. 7.1.4 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032)
  8. 7.2.2 North America HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032)
  11. 7.3.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bovaxbio
  2. 8.1.1 Bovaxbio Company Information
  3. 8.1.2 Bovaxbio Business Overview
  4. 8.1.3 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
  6. 8.1.5 Bovaxbio Recent Developments
  7. 8.2 Kangle Guardian
  8. 8.2.1 Kangle Guardian Company Information
  9. 8.2.2 Kangle Guardian Business Overview
  10. 8.2.3 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
  12. 8.2.5 Kangle Guardian Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck HPV Vaccine for Men(Male HPV Vaccine) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Wantai Biotech
  20. 8.4.1 Wantai Biotech Company Information
  21. 8.4.2 Wantai Biotech Business Overview
  22. 8.4.3 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
  24. 8.4.5 Wantai Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 HPV Vaccine for Men(Male HPV Vaccine) Value Chain Analysis
  2. 9.1.1 HPV Vaccine for Men(Male HPV Vaccine) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 HPV Vaccine for Men(Male HPV Vaccine) Production Mode & Process
  6. 9.2 HPV Vaccine for Men(Male HPV Vaccine) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 HPV Vaccine for Men(Male HPV Vaccine) Distributors
  9. 9.2.3 HPV Vaccine for Men(Male HPV Vaccine) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research